Turku University Hospital
Turku, Finland
NCT Number: NCT07780019
This prospective observational study aims to evaluate the effectiveness and acceptability of percutaneous or vaginal ultrasound guided microwave ablation for the treatment or symptomatic uterine fibroids. We will include 100 women.
This study is active but is not currently recruiting participants.
Notify Me18 year–56 year
Female
Observational
Turku, Finland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ultrasound guided percutaneus microwave ablation
Time frame: 12 months
Score of validated form Uterine Fibroid symptom - Quality of life questinnaire. minimum 0, maximum 100 where higher scores indicate higher symptom severity
Time frame: 12 months
objective and subjective outcome of mwa in different fibroid types, sizes and locations
Turku University Hospital
Other Gov
Prospective Observational Study of Microwave Ablation of Uterine Fibroids (MyoMwa)
Acronym: MyoMwa
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07474688
Leiomyoma, Neoplasms
Beijing, No. 2, Xinghua East Street, Chaoyang District, China
View Trial DetailsNCT07746349
Connective Tissue Diseases, Leiomyoma
View Trial DetailsNCT07352761
Blood Loss, Surgical, Hemorrhage
Alexandria, El-Shatby, Egypt
View Trial DetailsNCT07647198
Leiomyoma, Neoplasms
Abu Dhabi, United Arab Emirates (uae), United Arab Emirates
View Trial Details